<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">

Comprehensive Profiling of a Variety of I/O Models

Immunotherapies such as checkpoint inhibitors have achieved great success in treating cancer patients clinically. However, not all patients respond to these agents, most likely due to patients’ and/or tumors’ genetic and immunological makeup, particularly of the tumor microenvironment (TME).